1. Vineis, P, Wild, CP. Global cancer patterns: causes and prevention. Lancet 2014; 383:549–57
Google Scholar | Crossref | Medline | ISI2. Chen, W, Zheng, R, Baade, PD, Zhang, S, Zeng, H, Bray, F, Jemal, A, Yu, XQ, He, J. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66:115–32
Google Scholar | Crossref | Medline | ISI3. Zhou, M, Wang, H, Zeng, X, Yin, P, Zhu, J, Chen, W, Li, X, Wang, L, Wang, L, Liu, Y, Liu, J, Zhang, M, Qi, J, Yu, S, Afshin, A, Gakidou, E, Glenn, S, Krish, VS, Miller-Petrie, MK, Mountjoy-Venning, WC, Mullany, EC, Redford, SB, Liu, H, Naghavi, M, Hay, SI, Wang, L, Murray, CJL, Liang, X. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 2019; 394:1145–58
Google Scholar | Crossref | Medline4. Hall, EJ, Cox, JD. Physical and biologic basis of radiation therapy. In: Cox, JD, Ang, KK (eds) Radiation oncology. 9th ed. Philadelphia: Mosby, 2010, Chapter 1, pp. 3–49
Google Scholar5. Sharda, N, Yang, C-R, Kinsella, T, Boothman, D. Radiation resistance. In: Bertino, JR (ed.) Encyclopedia of cancer. 2nd ed. New York: Academic Press, 2002, pp. 1–11
Google Scholar | Crossref6. Linkous, AG, Yazlovitskaya, EM. Novel radiosensitizing anticancer therapeutics. Anticancer Res 2012; 32:2487–99
Google Scholar | Medline7. Santivasi, WL, Xia, F. Ionizing radiation-induced DNA damage, response, and repair. Antioxid Redox Signal 2014; 21:251–9
Google Scholar | Crossref | Medline8. Martin, LM, Marples, B, Coffey, M, Lawler, M, Lynch, TH, Hollywood, D, Marignol, L. DNA mismatch repair and the DNA damage response to ionizing radiation: making sense of apparently conflicting data. Cancer Treat Rev 2010; 36:518–27
Google Scholar | Crossref | Medline9. Umar, A, Kunkel, TA. DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur J Biochem 1996; 238:297–307
Google Scholar | Crossref | Medline10. Marra, G, Jiricny, J. DNA mismatch repair and colon cancer. Adv Exp Med Biol 2005; 570:85–123
Google Scholar | Crossref | Medline11. Jackson, T, Ahmed, MAH, Seth, R, Jackson, D, Ilyas, M. MLH1 function is context dependent in colorectal cancers. J Clin Pathol 2011; 64:141–5
Google Scholar | Crossref | Medline12. Rashid, S, Freitas, MO, Cucchi, D, Bridge, G, Yao, Z, Gay, L, Williams, M, Wang, J, Suraweera, N, Silver, A, McDonald, SAC, Chelala, C, Szabadkai, G, Martin, SA. MLH1 deficiency leads to deregulated mitochondrial metabolism. Cell Death Dis 2019; 10:795
Google Scholar | Crossref | Medline13. Ellison, AR, Lofing, J, Bitter, GA. Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain. Nucleic Acids Res 2004; 32:5321–38
Google Scholar | Crossref | Medline14. Blasi, MF, Ventura, I, Aquilina, G, Degan, P, Bertario, L, Bassi, C, Radice, P, Bignami, M. A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene. Cancer Res 2006; 66:9036–44
Google Scholar | Crossref | Medline15. Kawashima, N, Yoshida, H, Miwa, M, Fujiwara, K. MLH1 is a prognostic biomarker for serous ovarian cancer treated with platinum- and taxane-based chemotherapy. Anticancer Res 2019; 39:5505–13
Google Scholar | Crossref | Medline16. Yan, T, Seo, Y, Kinsella, TJ. Differential cellular responses to prolonged LDR-IR in MLH1-proficient and MLH1-deficient colorectal cancer HCT116 cells. Clin Cancer Res 2009; 15:6912–20
Google Scholar | Crossref | Medline17. Davis, TW, Wilson-Van Patten, C, Meyers, M, Kunugi, KA, Cuthill, S, Reznikoff, C, Garces, C, Boland, CR, Kinsella, TJ, Fishel, R, Boothman, DA. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res 1998; 58:767–78
Google Scholar | Medline18. Flanagan, SA, Krokosky, CM, Mannava, S, Nikiforov, MA, Shewach, DS. MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches. Mol Pharmacol 2008; 74:863–71
Google Scholar | Crossref | Medline19. Yan, T, Schupp, JE, Hwang, H-S, Wagner, MW, Berry, SE, Strickfaden, S, Veigl, ML, Sedwick, WD, Boothman, DA, Kinsella, TJ. Loss of DNA mismatch repair imparts defective cdc2 signaling and G2 arrest responses without altering survival after ionizing radiation. Cancer Res 2001; 61:8290–7
Google Scholar | Medline20. Mirzayans, R, Andrais, B, Scott, A, Wang, YW, Murray, D. Ionizing radiation-induced responses in human cells with differing TP53 status. Int J Mol Sci 2013; 14:22409–35
Google Scholar | Crossref | Medline | ISI21. Turnham, RE, Scott, JD. Protein kinase a catalytic subunit isoform PRKACA; history, function and physiology. Gene 2016; 577:101–8
Google Scholar | Crossref | Medline22. Neary, CL, Nesterova, M, Cho, YS, Cheadle, C, Becker, KG, Cho-Chung, YS. Protein kinase a isozyme switching: eliciting differential cAMP signaling and tumor reversion. Oncogene 2004; 23:8847–56
Google Scholar | Crossref | Medline23. Chin, C, Bae, JH, Kim, MJ, Hwang, JY, Kim, SJ, Yoon, MS, Lee, MK, Kim, DW, Chung, BS, Kang, CD, Kim, SH. Radiosensitization by targeting radioresistance-related genes with protein kinase a inhibitor in radioresistant cancer cells. Exp Mol Med 2005; 37:608–18
Google Scholar | Crossref | Medline